| Financial Year |
March 31 2023 |
| Monetary Funds |
463,057,799.17 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
324,835,855.76 |
| Advances to Suppliers |
154,470,276.14 |
| Other Receivables |
36,620,485.50 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
735,904,274.27 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
10,248,435.60 |
| Total Current Assets |
1,725,137,126.44 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
842,850.31 |
| Investment Properties |
-- |
| Fixed Assetes |
129,573,755.47 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
42,669,967.81 |
| R&D expenses |
-- |
| Goodwill |
84,013,912.51 |
| Long-Term Deferred and Prepaid Expenses |
2,204,707.68 |
| Deferred Income Tax Assets |
7,233,217.81 |
| Other Non-Current Assets |
343,873.17 |
| Sub-Total of Non-Current Assets |
286,594,320.80 |
| Total Assets |
2,011,731,447.24 |
| Short-Term Loans |
256,372,888.89 |
| Trading Financial liabilities |
-- |
| Notes Payable |
340,004,658.00 |
| Accounts Payable |
182,450,383.36 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
18,511,821.99 |
| Taxes Payable |
13,269,358.78 |
| Interest Payable |
-- |
| Dividend Payable |
9,382,499.46 |
| Other payables |
502,703,308.83 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
5,333,963.88 |
| Other Current Liabilities |
3,300,113.70 |
| Sub-Total of Current Liabilities |
1,583,513,520.45 |
| Long-term Loans |
266,933.33 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
22,897,039.00 |
| Total Liabilities |
1,606,410,559.45 |
| Paid-In Capital(Or Share Stock) |
380,240,380.00 |
| Capital Surplus |
208,354,374.29 |
| Surplus Reserve |
14,906,344.91 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-512,421,955.99 |
| Minority Stockholder's Interest |
310,996,371.68 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
94,324,516.11 |
| Owner's Equity（Stockholder's Equity） |
405,320,887.79 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,011,731,447.24 |
